Ipca Laboratories Limited, as a promoter of Krebs Biochemicals & Industries Ltd., has declared that there has been no encumbrance, directly or indirectly, on the equity shares held by them for the financial year ended March 31, 2026. This declaration is made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The declaration was submitted to the National Stock Exchange of India Ltd. and BSE Ltd. on April 2, 2026. Krebs Biochemicals and Industries Limited and the Audit Committee of its Board of Directors were also notified. Ipca Laboratories Limited is listed as the promoter and person acting in concert without a PAN for Krebs Biochemicals & Industries Ltd.
